Wcm Investment Management, LLC / WST
Wcm Investment Management, LLC’s West Pharmaceutical Svsc Inc Position
Does Wcm Investment Management, LLC own West Pharmaceutical Svsc Inc (WST)? Not currently — the last reported position was 1.24M shares worth $311M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$311M
Q3 2022
Shares
1.24M
% of Portfolio
+1.11%
Quarters Held
16
position exited
Position History WST
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 1.24M | $311M | +1.11% |
| Q2 2022 | 1.10M | $330M | +1.18% |
| Q1 2022 | 1.53M | $627M | +1.75% |
| Q4 2021 | 1.51M | $710M | +1.60% |
| Q3 2021 | 1.44M | $613M | +1.42% |
| Q2 2021 | 1.68M | $603M | +1.53% |
| Q1 2021 | 1.67M | $471M | +1.29% |
| Q4 2020 | 1.61M | $457M | +1.24% |
| Q3 2020 | 1.37M | $377M | +1.32% |
| Q2 2020 | 1.56M | $354M | +1.36% |
| Q1 2020 | 1.41M | $215M | +1.19% |
| Q4 2019 | 1.34M | $201M | +1.08% |
| Q3 2019 | 1.35M | $192M | +1.15% |
| Q2 2019 | 1.29M | $162M | +1.01% |
| Q1 2019 | 1.12M | $124M | +0.86% |
| Q4 2018 | 1.11M | $109M | +0.97% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wcm Investment Management, LLC’s full portfolio or all institutional holders of WST.